title: The medial preoptic area modulates cocaine-induced activity in female rats.
abstract: Drugs of abuse exert their effects by exploiting natural neurobiological reward mechanisms, especially the mesolimbic dopamine (DA) system. However, the mesolimbic system does not operate in isolation, and input from other reward-relevant structures may play a role in cocaine's rewarding effects. The medial preoptic area (mPOA) of the hypothalamus is involved in the regulation of two essential and naturally rewarding behaviors: sexual and maternal behaviors. It also makes strong neuroanatomical connections with areas of the mesolimbic system, particularly the ventral tegmental area (VTA). As such, the mPOA is a logical candidate for a neuroanatomical locus modulating activity in the mesolimbic system and emergent behavioral expressions of drug reward, yet the role of this structure is largely unexplored. Here, using a female rat model, we show that the mPOA innervates the VTA in a region-specific manner, that lesions of the mPOA augment cocaine-induced Fos expression in the nucleus accumbens (NAc) and cocaine-induced conditioned place preference. We also show that approximately 68% of mPOA-VTA efferents release γ-aminobutyric acid (GABA), over 75% are sensitive to DA as evidenced by colocalization with DA receptors, and nearly 60% of these contain both DA receptors and GABA, which suggests a novel key role for the mPOA in the inhibition of the mesolimbic DA circuit. Combined, these results reveal the mPOA as a critical modulating structure in cocaine-induced mesolimbic activity and behavioral manifestation of reward, at least in part, via GABAergic output that is sensitive to DA input.
authors.affiliation: Department of Psychology, University of Texas at Austin, Austin, TX 78712, USA.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Tobiansky
authors.forename: Peter G
authors.initials: PG
authors.lastname: Roma
authors.forename: Tomoko
authors.initials: T
authors.lastname: Hattori
authors.forename: Ryan G
authors.initials: RG
authors.lastname: Will
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Nutsch
authors.forename: Juan M
authors.initials: JM
authors.lastname: Dominguez
mesh_terms: D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects* / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D005260:Female; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D011301:Preoptic Area / Q000187:drug effects* / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011954:Receptors, Dopamine / Q000378:metabolism; D012201:Reward; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
chemical_list: D018765:Dopamine Uptake Inhibitors; D016760:Proto-Oncogene Proteins c-fos; D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid; D003042:Cocaine; D004298:Dopamine
references.citation: Psychopharmacology (Berl). 1983;81(2):158-63
references.pmid: 6415748
references.citation: Science. 1971 Aug 20;173(3998):731-3
references.pmid: 5568506
references.citation: Synapse. 1990;5(1):48-58
references.pmid: 2300906
references.citation: Brain Res Bull. 1997;44(4):397-407
references.pmid: 9370204
references.citation: Biol Psychiatry. 2010 Jan 1;67(1):88-92
references.pmid: 19748079
references.citation: Ann N Y Acad Sci. 2001 Jun;937:172-87
references.pmid: 11458536
references.citation: Horm Behav. 2002 Nov;42(3):258-62
references.pmid: 12501837
references.citation: Brain Res. 1978 Jun 16;148(2):333-46
references.pmid: 656937
references.citation: Physiol Behav. 1994 Apr;55(4):615-20
references.pmid: 8190785
references.citation: Eur J Neurosci. 2003 Oct;18(7):1997-2001
references.pmid: 14622232
references.citation: Physiol Behav. 1999 Nov;67(5):659-69
references.pmid: 10604835
references.citation: Neuron. 2009 Mar 12;61(5):786-800
references.pmid: 19285474
references.citation: Psychopharmacology (Berl). 1986;89(3):340-6
references.pmid: 3088661
references.citation: Brain Res. 2006 Mar 3;1076(1):163-70
references.pmid: 16473334
references.citation: Pharmacol Biochem Behav. 1993 Jul;45(3):673-6
references.pmid: 7687357
references.citation: Pharmacol Biochem Behav. 1979 Nov;11(5):553-6
references.pmid: 531077
references.citation: Psychopharmacology (Berl). 1995 Nov;122(2):194-7
references.pmid: 8848536
references.citation: Horm Behav. 2007 Jun;52(1):45-55
references.pmid: 17499249
references.citation: J Comp Neurol. 2007 Sep 1;504(1):42-56
references.pmid: 17614295
references.citation: J Neurosci. 2001 Mar 15;21(6):2123-30
references.pmid: 11245696
references.citation: J Neurosci. 1997 Nov 1;17(21):8580-7
references.pmid: 9334429
references.citation: Neuroscience. 2003;120(2):523-33
references.pmid: 12890521
references.citation: Neuroscience. 2008 Apr 9;152(4):1024-31
references.pmid: 18355970
references.citation: Brain Res Mol Brain Res. 1992 Jul;14(3):239-49
references.pmid: 1331652
references.citation: Eur J Neurosci. 2001 Mar;13(5):1009-15
references.pmid: 11264674
references.citation: Psychopharmacology (Berl). 1984;84(2):167-73
references.pmid: 6438676
references.citation: Behav Neurosci. 2000 Dec;114(6):1191-202
references.pmid: 11142651
references.citation: Behav Neurosci. 1991 Oct;105(5):727-43
references.pmid: 1840012
references.citation: Psychopharmacology (Berl). 2002 Feb;159(4):397-406
references.pmid: 11823892
references.citation: J Comp Neurol. 1988 Apr 8;270(2):209-42
references.pmid: 3259955
references.citation: Neuropsychopharmacology. 2010 Jan;35(2):445-63
references.pmid: 19794406
references.citation: Neuropsychopharmacology. 2012 Apr;37(5):1164-76
references.pmid: 22169942
references.citation: Behav Neurosci. 1997 Apr;111(2):369-80
references.pmid: 9106676
references.citation: Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1291-5
references.pmid: 1825356
references.citation: Neuron. 2012 Mar 22;73(6):1184-94
references.pmid: 22445345
references.citation: Life Sci. 1983 Dec 19;33(25):2551-7
references.pmid: 6645814
references.citation: J Comp Neurol. 1978 Aug 1;180(3):545-80
references.pmid: 659674
references.citation: Trends Pharmacol Sci. 2004 May;25(5):273-9
references.pmid: 15120494
references.citation: Neurosci Biobehav Rev. 2011 Jan;35(3):826-47
references.pmid: 20955733
references.citation: Nat Neurosci. 2005 Nov;8(11):1445-9
references.pmid: 16251986
references.citation: Psychopharmacology (Berl). 2002 Nov;164(2):121-37
references.pmid: 12404074
references.citation: Neuroscience. 1985 Oct;16(2):275-96
references.pmid: 4080159
references.citation: J Physiol. 2006 Dec 15;577(Pt 3):907-24
references.pmid: 16959856
references.citation: Behav Brain Res. 1999 Nov 1;105(1):105-16
references.pmid: 10553694
references.citation: Horm Behav. 2001 Sep;40(2):93-8
references.pmid: 11534968
references.citation: Brain Res Bull. 1982 Jul-Dec;9(1-6):321-53
references.pmid: 6816390
references.citation: J Comp Neurol. 1997 Dec 1;388(4):507-25
references.pmid: 9388012
references.citation: Behav Neurosci. 2007 Dec;121(6):1224-33
references.pmid: 18085876
references.citation: AMA Arch Neurol Psychiatry. 1953 Aug;70(2):224-34
references.pmid: 13064883
references.citation: Front Neuroendocrinol. 2009 Jan;30(1):46-64
references.pmid: 19022278
references.citation: Brain Res. 1996 Dec 2;742(1-2):163-71
references.pmid: 9117390
references.citation: Exp Clin Psychopharmacol. 2006 Feb;14(1):34-41
references.pmid: 16503703
references.citation: Curr Opin Neurobiol. 1999 Dec;9(6):751-8
references.pmid: 10607643
references.citation: Behav Neurosci. 1992 Feb;106(1):181-91
references.pmid: 1313243
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(17):6912-6
references.pmid: 2118661
references.citation: Neuron. 1998 Sep;21(3):467-76
references.pmid: 9768834
references.citation: J Physiol. 1992 May;450:455-68
references.pmid: 1331427
references.citation: Psychopharmacology (Berl). 1994 Apr;114(3):477-85
references.pmid: 7855206
references.citation: Behav Brain Res. 2000 Mar;108(2):215-31
references.pmid: 10701665
references.citation: Psychopharmacology (Berl). 1991;103(2):271-6
references.pmid: 1674160
references.citation: Front Neuroendocrinol. 2007 Oct;28(4):161-78
references.pmid: 17624413
references.citation: Neuron. 2002 Oct 10;36(2):229-40
references.pmid: 12383779
references.citation: Behav Neurosci. 1994 Aug;108(4):724-34
references.pmid: 7986366
references.citation: J Comp Neurol. 2011 Nov 1;519(16):3159-88
references.pmid: 21618227
references.citation: J Neurochem. 1997 Jul;69(1):137-43
references.pmid: 9202304
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):461-71
references.pmid: 17924780
references.citation: J Comp Neurol. 1990 Apr 1;294(1):76-95
references.pmid: 2324335
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):282-9
references.pmid: 15169831